Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Garris, Christopher S., Arlauckas, Sean P., Kohler, Rainer H., Trefny, Marcel P., Garren, Seth, Piot, Cécile, Engblom, Camilla, Pfirschke, Christina +15 more·2018·Immunity

DOI 10.1016/j.immuni.2018.09.024

Cited by (970)

Items 201–300 of 970

ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
Brian B. Haines, Agnieszka Denslow, Peter Grzesik, Jennifer S. Lee, Terry Farkaly, Jacqueline Hewett, Daniel Wambua, Lingxin Kong, Prajna Behera, Judith Jacques et al. · 2020 · Cancer Immunology Research
Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)
Xiubao Ren, Zhenzhen Hui, Jiali Zhang, Yulin Ren, XIAOLING LI, Cihui Yan, Tao Wang, Wenwen Yu, Tao Wang, Shanshan Xiao et al. · 2022 · Cell Death and Disease
Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune Responses
Peng Zheng, Jinrong He, Yuting Fu, Ying Yang, Shuqin Li, Biao Duan, Ying Yang, Yongmao Hu, Zhongqian Yang, Mengzhen Wang et al. · 2024 · ACS Nano
An artificial metabzyme for tumour-cell-specific metabolic therapy
Xi Hu, Bo Zhang, Miao Zhang, Wenshi Liang, Bangzhen Hong, Zhiyuan Ma, Jianpeng Sheng, Tianqi Liu, Shengfei Yang, Zeyu Liang et al. · 2024 · Nature Nanotechnology
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, Najmaldin Saki, Mohammad Ali Jalali Far, Arshid Yousefi Avarvand, Kiana Dost Mohammad Ghasemi, Mojtaba Aghaei, Mohammad Mehdi Abolhasani, Mohammad Sharif Sharifani et al. · 2024 · Iranian Journal of Blood and Cancer
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
Feng Lin, Shenyi Yin, Zijian Zhang, Ying Yu, Haoming Fang, Zhen Liang, Rujie Zhu, Haitao Zhou, Jianjie Li, Kunxia Cao et al. · 2024 · Cell
Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment
Minyuan Cao, Yun Deng, Qing Hao, Huayun Yan, Q Wang, Chunyan Dong, Jing Wu, Yong He, Li‐Bin Huang, Xuyang Xia et al. · 2025 · Signal Transduction and Targeted Therapy
Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications
Annalisa Del Prete, Francesca Sozio, Ilaria Barbazza, Valentina Salvi, Laura Tiberio, Mattia Laffranchi, Angela Gismondi, Daniela Bosisio, Tiziana Schioppa, Silvano Sozzani · 2020 · International Journal of Molecular Sciences
The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era
Nikolaos Spyrou, Natalia G. Vallianou, Jona Kadillari, Μaria Dalamaga · 2021 · Seminars in Cancer Biology
Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse
Emma Lindell, Lei Zhong, Xiaonan Zhang · 2023 · International Journal of Molecular Sciences
Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors
Lin Zhang, Chao Zhou, Songou Zhang, Xiaozhen Chen, Jian Liu, Fangming Xu, Wenqing Liang · 2022 · Frontiers in Oncology
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
Bhavana Palakurthi, Shaneann R. Fross, Ian H. Guldner, Emilija Aleksandrovic, Xiyu Liu, Anna K. Martino, Qingfei Wang, Ryan A. Neff, Samantha M. Golomb, Cheryl M. Lewis et al. · 2023 · Nature Communications
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Johanna Bödder, Tasmin Zahan, Rianne van Slooten, Gerty Schreibelt, I. Jolanda M. de Vries, Georgina Flórez‐Grau · 2021 · Frontiers in Immunology
The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets
Chae Won Kim, Kyun‐Do Kim, Heung Kyu Lee · 2021 · BMB Reports
Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance
Jingjing Deng, Mei Ling Zhou, Tingting Liao, Wenlong Kuang, Hui Xia, Zhengrong Yin, Qi Tan, Yumei Li, Siwei Song, E Zhou et al. · 2022 · Frontiers in Cell and Developmental Biology
Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
Dmitry V. Chouljenko, Jun Ding, I‐Fang Lee, Yanal M. Murad, Xuexian Bu, Guoyu Liu, Zahid M. Delwar, Yi Sun, Sheng Yu, Ismael J. Samudio et al. · 2020 · Biomedicines
Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy
Jannie G. Borst, Julia Busselaar, Douwe M. T. Bosma, FERRY A. OSSENDORP · 2021 · European Journal of Immunology
Inhalable pH-responsive DNA tetrahedron nanoplatform for boosting anti-tumor immune responses against metastatic lung cancer
Fan Qin, Zhihao Li, Jue Yin, Mo Xie, Mei-Rong Cui, Chunhai Fan, Lianhui Wang, Jie Chao · 2023 · Biomaterials
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints
Kristian Michael Hargadon · 2020 · Clinical and Translational Medicine
Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation
Sachin H. Bhagchandani, Farrukh Vohidov, Lauren E. Milling, Yuzhou Evelyn Tong, Christopher M. Brown, Michelle L. Ramseier, Bin Liu, Tim B. Fessenden, Hung V.‐T. Nguyen, Gavin R. Kiel et al. · 2023 · Science Advances
Improving nanotherapy delivery and action through image-guided systems pharmacology
Ng, Thomas S.C., Garlin, Michelle A., Weissleder, Ralph, Miller, Miles A. · 2020 · Theranostics
Oral administration of Bifidobacterium breve promotes antitumor efficacy via dendritic cells-derived interleukin 12
Qingxiang Li, Yuke Li, Yifei Wang, Le Xu, Yuxing Guo, Yixiang Wang, Lin Wang, Chuanbin Guo · 2021 · OncoImmunology
Cell membrane coated nanoparticles as a biomimetic drug delivery platform for enhancing cancer immunotherapy
Zichen Zhong, Wen Deng, Jian Wu, Haojie Shang, Yonghua Tong, He Yu, Qiu Huang, Xiaozhuo Ba, Zhiqiang Chen, Kun Tang · 2024 · Nanoscale
Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer
Meriem Belabed, Matthew D. Park, Cédric M. Blouin, Sreekumar Balan, Chang Yoon Moon, Grace S. Freed, Miguel Quijada‐Álamo, Ante Peros, Raphaël Mattiuz, Amanda M. Reid et al. · 2025 · Nature Immunology
Cytokines as potential combination agents with PD‐1/PD‐L1 blockade for cancer treatment
Ghasem Rahimi Kalateh Shah Mohammad, Atefeh Ghahremanloo, Arash Soltani, Esmat Fathi, Seyed Isaac Hashemy · 2020 · Journal of Cellular Physiology
Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies
Aleksandra Filipović, George Miller, Joseph B. Bolen · 2020 · Frontiers in Cell and Developmental Biology
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4 + and CD8 + T‐cell protective responses to breast cancer
Raphaël Mattiuz, Carine Brousse, Marc Ambrosini, Jean-Charles Cancel, Gilles Bessou, Julie Mussard, Amélien Sanlaville, Christophe Caux, Nathalie Bendriss‐Vermare, Jenny Valladeau‐Guilemond et al. · 2021 · Clinical & Translational Immunology
Apoptotic Body-Mediated Intracellular Delivery Strategy for Enhanced STING Activation and Improved Tumor Immunogenicity
Peng Bao, Zitong Zheng, Jing‐Jie Ye, Xian‐Zheng Zhang · 2022 · Nano Letters
CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells
Yuhan Zhang, Junyi Hu, Kai Ji, Shengpeng Jiang, Yang Dong, Lin Sun, Jun Wang, Guangyuan Hu, Dawei Chen, Ke Chen et al. · 2023 · Cell Reports Medicine
Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches
Joseph Tintelnot, Alexander Stein · 2019 · World Journal of Gastroenterology
Harnessing in situ glutathione for effective ROS generation and tumor suppression via nanohybrid-mediated catabolism dynamic therapy
Si‐Yuan Peng, Xinhua Liu, Qi‐Wen Chen, Yunjian Yu, Miao‐Deng Liu, Xian‐Zheng Zhang · 2021 · Biomaterials
Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy
Qian Hu, Lihuan Shang, Mengmeng Wang, Kun Tu, Mei Ying Hu, Yulin Yu, Mingwang Xu, Li Kong, Yuanyuan Guo, Zhiping Zhang · 2020 · Advanced Healthcare Materials
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization
Alycia Gardner, Álvaro de Mingo Pulido, Kay Hänggi, Sarah Bazargan, Alexis Onimus, Agnieszka Kasprzak, Jose Ramon Conejo-Garcia, Katarzyna Anna Rejniak, Brian Ruffell · 2022 · Journal for ImmunoTherapy of Cancer
High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity
Eva Karamitopoulou, Andréas Andreou, Anna Silvia Wenning, Beat Gloor, Aurel A. Perren · 2022 · European Journal of Cancer
Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy
Larsen Vornholz, Sophie E. Isay, Zsuzsanna Kurgyis, Daniel C. Strobl, Patricia Loll, Mohammed H. Mosa, Malte D. Luecken, Michael Sterr, Heiko Lickert, Christof Winter et al. · 2023 · Science Advances
Interleukin-12 as an in situ cancer vaccine component: a review
Emily M. Cheng, Noah W. Tsarovsky, Paul M. Sondel, Alexander L. Rakhmilevich · 2022 · Cancer Immunology Immunotherapy
Antigen-derived peptides engage the ER stress sensor IRE1α to curb dendritic cell cross-presentation
Ofer Guttman, Adrien Le Thomas, Scot A. Marsters, David A. Lawrence, Lauren M. Gutgesell, Iratxe Zuazo-Gaztelu, Jonathan M. Harnoss, Simone M. Haag, Aditya Murthy, Geraldine A. Strasser et al. · 2022 · The Journal of Cell Biology
From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
Xuan Zhao, Yulin Bao, Bi Meng, Zijian Xu, Sijin Li, Xu Wang, Rui Hou, Wen Ma, Dan Liu, Junnian Zheng et al. · 2022 · Frontiers in Immunology
Microbial cancer immunotherapy reprograms hematopoiesis to enhance anti-tumor immunity
Andrew W. Daman, Anthony C. Antonelli, Gil Redelman‐Sidi, Lucinda Paddock, Shireen Khayat, Mythili Ketavarapu, Jin‐Gyu Cheong, Leonardo F. Jurado, Anna Benjamin, Song Jiang et al. · 2024 · Cancer Cell
Regulators of T‐cell fate: Integration of cell migration, differentiation and function
Joanna R. Groom · 2019 · Immunological Reviews
Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
Zhenqing Wang, Liang Chen, Yiqun Ma, Xilei Li, Annan Hu, Wenxing Wang, Wenxing Wang, Xiaomin Li, Bo Tian, Jian Dong · 2021 · Journal of Nanobiotechnology
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
Snehanshu Chowdhury, Anwesha Kar, Debaleena Bhowmik, Anupam Gautam, Debashree Basak, Ishita Sarkar, Puspendu Ghosh, Deborpita Sarkar, Alvina Deka, Paramita Chakraborty et al. · 2022 · Cancer Research
Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies
Christine Mall Minnar, Paul L. Chariou, Lucas A. Horn, Kristin C. Hicks, Claudia Palena, Jeffrey Schlom, Sofia R. Gameiro · 2022 · Journal for ImmunoTherapy of Cancer
Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity
Caleb R. Stoltzfus, Ramya Sivakumar, Leo Kunz, Brandy E. Olin, Elena Menietti, Dario Speziale, Roberto Adelfio, Marina Bacac, Sara Colombetti, Mario Perro et al. · 2021 · Frontiers in Immunology
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery
Jiao Shen, Zhuangzhi Zou, Jingya Guo, Yueqi Cai, Diyuan Xue, Yong Liang, Wenyan Wang, Hua Peng, Yang‐Xin Fu · 2022 · The Journal of Experimental Medicine
An oncolytic virus–delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment
Kristin DePeaux, Dayana B. Rivadeneira, Konstantinos Lontos, Victoria G. Dean, William G. Gunn, McLane J. Watson, Tianhong Yao, Drew N. Wilfahrt, Cynthia S. Hinck, Łukasz Wieteska et al. · 2023 · The Journal of Experimental Medicine
Humanized Mouse Models to Evaluate Cancer Immunotherapeutics
Silvia Guil‐Luna, Christine Sedlik, Eliane Piaggio · 2021 · Annual Review of Cancer Biology
Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment
Lihuan Shang, Xue Jiang, Ting Yang, Hongbo Xu, Qi Xie, Mei Ying Hu, Conglian Yang, Li Kong, Zhiping Zhang · 2021 · Acta Pharmaceutica Sinica B
Tumor Immunosurveillance and Immunotherapies: A Fresh Look from Intravital Imaging
Morgane Boulch, Capucine L. Grandjean, Marine Cazaux, Philippe Bousso · 2019 · Trends in Immunology
Human CD141 + dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model
Yoke Seng Lee, Liam O’Brien, Carina Walpole, Frances Elizabeth Pearson, Ingrid Leal Rojas, Kelly‐Anne Masterman, Victoria G. Atkinson, Andrew P. Barbour, Kristen J. Radford · 2021 · Journal for ImmunoTherapy of Cancer
Tumor‐associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevance
Ioana Plesca, Luise Müller, Jan P. Böttcher, Hind Medyouf, Rebekka Wehner, Marc Schmitz · 2022 · European Journal of Immunology
DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation
Francisco J. Cueto, Carlos del Fresno, David Sancho · 2020 · Frontiers in Immunology
The depths of PD-1 function within the tumor microenvironment beyond CD8+ T cells
Stephanie Laba, Grace Mallett, Shoba Amarnath · 2021 · Seminars in Cancer Biology
The expanding landscape of inflammatory cells affecting cancer therapy
Ralph Weissleder, Mikaël J. Pittet · 2020 · Nature Biomedical Engineering
Galactosylated chitosan-modified ethosomes combined with silk fibroin nanofibers is useful in transcutaneous immunization
Xingxing Yang, Xiaoyun Wang, Huoyan Hong, Gomaa F. El Fawal, Si Lin, Jinglei Wu, Yuxin Jiang, Chuanglong He, Xiumei Mo, Guoyin Kai et al. · 2020 · Journal of Controlled Release
The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies
Oliviero Marinelli, Daniela Annibali, Cristina Aguzzi, Sandra Tuyaerts, Frédéric C. Amant, Maria Beatrice Morelli, Giorgio Santoni, Consuelo Amantini, Federica Maggi, Massimo Nabissi · 2019 · Frontiers in Oncology
Metastatic Colonization: Escaping Immune Surveillance
Julien Schaller, Judith Agudo · 2020 · Cancers
Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy
Zhisong Wang, Yan Gao, Lei He, Shuhao Sun, Tingting Xia, Lu Hu, Licheng Yao, Liangliang Wang, Dan Li, Hui Min Shi et al. · 2021 · Journal of Medicinal Chemistry
Secretions From Hypochlorous Acid-Treated Tumor Cells Delivered in a Melittin Hydrogel Potentiate Cancer Immunotherapy
Zhou, Yuhan, Ye, Ting, Ye, Chengzhi, Wan, Chao, Yuan, Siyue, Liu, Yushuai, Li, Tianyu, Jiang, Fagang, Lovell, Jonathan F., Jin, Honglin et al. · 2022 · Bioactive Materials
XCL1 / Glypican-3 Fusion Gene Immunization Generates Potent Antitumor Cellular Immunity and Enhances Anti–PD-1 Efficacy
Kun Chen, Zhiyuan Wu, Hong Zhao, Yanmei Wang, Yutong Ge, Dongmei Wang, Zhengjiang Li, Changming An, Yuying Liu, Feifei Wang et al. · 2019 · Cancer Immunology Research
LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
Suyeon Kim, Hanbyoul Cho, Soon-Oh Hong, Se Jin Oh, Hyo-Jung Lee, Eunho Cho, Seon Rang Woo, Joon Seon Song, Joon‐Yong Chung, Sung Wook Son et al. · 2020 · Autophagy
Alpha-type-1 Polarized Dendritic Cell-based Vaccination in Newly Diagnosed High-grade Glioma: A Phase II Clinical Trial
Koichi Mitsuya, Yasuto Akiyama, Akira Iizuka, Haruo Miyata, Shoichi Deguchi, Nakamasa Hayashi, Chie Maeda, Ryota Kondou, Akari Kanematsu, Kyoko Watanabe et al. · 2020 · Anticancer Research
Ultra‐fast Cycling for Multiplexed Cellular Fluorescence Imaging
Jina Ko, Juhyun Oh, Maaz S. Ahmed, Jonathan Carlson, Ralph Weissleder · 2020 · Angewandte Chemie International Edition
Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity
Yufeng Wang, Mei Ling Song, Ming Liu, Guoan Zhang, Xian Zhang, Ming O. Li, Xiaojing Ma, J. Jillian Zhang, Xin‐Yun Huang · 2021 · Cell Reports
Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice
Cangang Zhang, Lei Lei, Xiaofeng Yang, Kaili Ma, Huiqiang Zheng, Yanhong Su, Anjun Jiao, Xin Wang, Haiyan Liu, Yujing Zou et al. · 2021 · Journal for ImmunoTherapy of Cancer
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
Natasa Prokopi, Christoph H. Tripp, Bart Tummers, Florian Hornsteiner, Sarah Spoeck, Jeremy Chase Crawford, Derek R. Clements, Mirjana Efremova, Katharina Hutter, Lydia Bellmann et al. · 2021 · Journal for ImmunoTherapy of Cancer
Functions of Dendritic Cells and Its Association with Intestinal Diseases
Zejun Yang, Boya Wang, Tiantian Wang, Feifei Wang, Yuexin Guo, Rongxuan Hua, Hongwei Shang, Xin Lü, Jingdong Xu · 2021 · Cells
Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy
Huijuan Song, Qi Su, Weifeng Shi, Pingsheng Huang, Chuangnian Zhang, Chao Zhang, Qiang Liu, Weiwei Wang · 2022 · Acta Biomaterialia
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
Francisco J. Cueto, Carlos del Fresno, Paola Brandi, Alexis J. Combes, Elena Hernández-García, Alfonso R. Sánchez-Paulete, Michel Enamorado, Christian P. Bromley, Manuel J. Gómez, Ruth Conde‐Garrosa et al. · 2021 · Journal for ImmunoTherapy of Cancer
The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer
Beatriz Subtil, Alessandra Cambi, Daniele V. F. Tauriello, I. Jolanda M. de Vries · 2021 · Frontiers in Immunology
CAR T-cells for colorectal cancer immunotherapy: Ready to go?
Bouchra Ghazi, Adil El Ghanmi, Sarah Kandoussi, Amina Ghouzlani, Abdallah Badou · 2022 · Frontiers in Immunology
PD‐L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer
Timothy J. Miller, Chidozie C. Anyaegbu, Tracey F. Lee‐Pullen, Lisa Jane Spalding, Cameron F E Platell, Melanie J. McCoy · 2020 · Cancer Science
Transcutaneous tumor vaccination combined with anti-programmed death-1 monoclonal antibody treatment produces a synergistic antitumor effect
Xinran Song, Yuxin Jiang, Weixing Zhang, Gomaa F. El Fawal, Kaili Wang, Di Maria Jiang, Huoyan Hong, Jinglei Wu, Chuanglong He, Xiumei Mo et al. · 2021 · Acta Biomaterialia
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments
Julia Moreno-Vicente, Jane E. Willoughby, Martin C Taylor, Steven G. Booth, Vikki English, Emily L. Williams, Christine A. Penfold, Christopher Ian Mockridge, Tatyana Inzhelevskaya, Jinny Kim et al. · 2022 · Journal for ImmunoTherapy of Cancer
Checkpoint inhibitor/interleukin‐based combination therapy of cancer
Keywan Mortezaee, Jamal Majidpoor · 2022 · Cancer Medicine
Mapping and Validation of scRNA-Seq-Derived Cell-Cell Communication Networks in the Tumor Microenvironment
Kate Bridges, Kathryn Miller‐Jensen · 2022 · Frontiers in Immunology
Type 1 conventional dendritic cells: ontogeny, function, and emerging roles in cancer immunotherapy
Shengbo Zhang, Michaël Chopin, Stephen L. Nutt · 2021 · Trends in Immunology
Clinical and Antitumor Immune Responses in Relapsed/Refractory Follicular Lymphoma Patients after Intranodal Injections of IFNα-Dendritic Cells and Rituximab: a Phase I Clinical Trial
Maria Christina Cox, Luciano Castiello, Mauro Mattei, Laura Santodonato, Giuseppina D’Agostino, Elena Muraro, Debora Martorelli, Caterina Lapenta, Arianna Di Napoli, Francesca Di Landro et al. · 2019 · Clinical Cancer Research
Interplay between dendritic cells and cancer cells
Jan Martínek, Te-Chia Wu, Diana Cadena, Jacques Banchereau, Karolina Palucka · 2019 · International review of cytology
Adjuvant-free peptide vaccine targeting Clec9a on dendritic cells can induce robust antitumor immune response through Syk/IL-21 axis
Shanshan Gou, Shuai Wang, Wenwen Liu, Guanyu Chen, Dongyang Zhang, Jiangfeng Du, Zhongyi Yan, Hongfei Wang, Wenjie Zhai, Xinghua Sui et al. · 2021 · Theranostics
Chemiluminescence resonance energy transfer-based immunostimulatory nanoparticles for sonoimmunotherapy
Jueun Jeon, Been Yoon, Seok Ho Song, Wooram Um, Yeari Song, Jeongjin Lee, Dong Gil You, Jae Yoon An, Jae Hyung Park · 2022 · Biomaterials
Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells
Tarun Tyagi, Kanika Jain, Timur Olegovich Yarovinsky, Michael Chiorazzi, Jing Du, Cecilia Castro, Julian Leether Griffin, Asawari Korde, Kathleen A. Martin, Shervin S. Takyar et al. · 2022 · The Journal of Experimental Medicine
IL-12 Signaling Promotes TET2-Mediated DNA Demethylation During CD8 T Cell Effector Differentiation
Caitlin C. Zebley, Hossam Aly Abdelsamed, Hazem E. Ghoneim, Shanta Alli, Charmaine Brown, Dalia Haydar, Mi Tian, Tarsha L. Harris, Maureen Ann McGargill, Giedre Krenciute et al. · 2020 · Cell Reports
Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti‐Tumor Immunity in Murine Glioblastoma
Sophie Lugani, Elias A. Halabi, Juhyun Oh, Rainer H. Köhler, Hannah M. Peterson, Xandra O. Breakefield, Ennio Antonio Chiocca, Miles Aaron Miller, Christopher Garris, Ralph Weissleder · 2022 · Advanced Materials
DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps
Degao Chen, Zheng Jin, Chu Han, Yucui Wu, Yangping Bian, Ting Yuan, Hao Lv, Qiuyu Xia, Lei Wang, Qian Chu et al. · 2025 · Cancer Cell
What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
Qingyi Wang, Bin Xie, Shuang Liu, Ying Shi, Yongguang Tao, Desheng Xiao, Wenxiang Wang · 2021 · Frontiers in Immunology
Penpulimab, an Fc-Engineered IgG1 Anti-PD-1 Antibody, With Improved Efficacy and Low Incidence of Immune-Related Adverse Events
Zhaoliang Huang, Xinghua Pang, Tingting Zhong, Tailong Qu, Na Chen, Shun Ma, Xinrong He, Dennis Xia, Max Wang, Michelle Xia et al. · 2022 · Frontiers in Immunology
In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
Chenkai Mao, Veronique Beiss, Gregory W Ho, Jennifer L. Fields, Nicole F. Steinmetz, Steven Fiering · 2022 · Journal for ImmunoTherapy of Cancer
Once upon a prime: DCs shape cancer immunity
Maria Zagorulya, Stefani Spranger · 2022 · Trends in cancer
Unraveling the Heterogeneity and Ontogeny of Dendritic Cells Using Single-Cell RNA Sequencing
Binyao Chen, Lei Zhu, Shizhao Yang, Wenru Su · 2021 · Frontiers in Immunology
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
Ornella Franzese, Grazia Graziani · 2022 · Cancers
Dendritic cell subsets and implications for cancer immunotherapy
Michael Y. Chen, Felicia Zhang, Simon Peter Goedegebuure, William E. Gillanders · 2024 · Frontiers in Immunology
DNT Cell-based Immunotherapy: Progress and Applications
Yingrui Li, Kang Dong, Xueke Fan, Jun Xie, Miao Wang, Songtao Fu, Qin Li · 2020 · Journal of Cancer
CRISPR screen in mechanism and target discovery for cancer immunotherapy
Dan Liu, Xuan Zhao, Anqun Tang, Xiyue Xu, Shuci Liu, Li Zha, Wen Ma, Junnian Zheng, Ming Shi · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Single-cell analyses reveal the clonal and molecular aetiology of Flt3L-induced emergency dendritic cell development
Dawn S. Y. Lin, Luyi Tian, Sara Tomei, Daniela Amann‐Zalcenstein, Tracey M. Baldwin, Tom Weber, Jaring Schreuder, Olivia J. Stonehouse, Jai Rautela, Nicholas D. Huntington et al. · 2021 · Nature Cell Biology
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors
Sara Labiano, Vincent Roh, Céline Godfroid, Agnès Hiou‐Feige, Jackeline F. Romero, Eva Sum, Moritz Rapp, Gaël Boivin, Tania Wyss, Christian Simon et al. · 2021 · Clinical Cancer Research
PD-1 and PD-L1 inhibitors foster the progression of adult T-cell Leukemia/Lymphoma
Mohammad Jalili‐Nik, Arash Soltani, Baratali Mashkani, Houshang Rafatpanah, Seyed Isaac Hashemy · 2021 · International Immunopharmacology
Macrophage-Targeted Therapy Unlocks Antitumoral Cross-talk between IFNγ-Secreting Lymphocytes and IL12-Producing Dendritic Cells
Christina Pfirschke, Rapolas Žilionis, Camilla Engblom, Marius Messemaker, Angela E. Zou, Steffen Rickelt, Nicolas A. Gort-Freitas, Yunkang Lin, Ruben Bill, Marie Siwicki et al. · 2021 · Cancer Immunology Research
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, Yu Fan, Junlong Zhang, Bei Cai, Yan Lin, Yao Luo, Yi Li · 2024 · International Immunopharmacology
Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Mathilde Ruggiu, Marion V. Guérin, Béatrice Corre, Margot Bardou, Ruby Alonso, Erica Russo, Zacarias Garcia, Lea Feldmann, Fabrice Lemaı̂tre, Mathilde Dusséaux et al. · 2024 · The Journal of Experimental Medicine